Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

The Office of Personnel Management (OPM) will again report on how much time and money federal employees spend on union activity after a hiatus during the Biden administration following a request from ...

The Office of Personnel Management (OPM) will again report on how much time and money federal employees spend on union activity after a hiatus during the Biden administration following a request ...

The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw a resurgence, signaling renewed investor confidence ...

The classification of HIV/Aids and TB in the pandemics category, rather than chronic diseases, has made thousands of patients pay out-of-pocket for services that should be covered under the national ...

The company’s streaming operation, which has 72 million subscribers, will be under scrutiny for not only subscriber growth but a long-awaited turn toward profitability. Peers in the media sector ...

After a lifetime on the frontiers of the fight against HIV, Linda-Gail Bekker could finally ... Because ultimately, if we can bring this epidemic under control more quickly, it’s going to ...